A genomic point-of-view on environmental factors influencing the human brain methylome

Epigenetics

Volumn 6, Issue 7, 2011, Pages 862-869

  LaSalle, Janine M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alu; Autism; Copy number variation; DNA methylation; Environmental exposures; Epigenetics; Epigenomics; Folate; Folic acid; Genomics; LINE 1; MeCP2; Neurodevelopment

Indexed keywords

ARSENIC; BENZENE; BRAIN DERIVED NEUROTROPHIC FACTOR; CADMIUM; CYTOSINE; DIETHYLSTILBESTROL; DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; FOLIC ACID; METHYLMERCURY; ORGANOCHLORINE PESTICIDE; POLYBROMINATED DIPHENYL ETHER; POLYCHLORINATED BIPHENYL; RIBOSOME DNA;

AIR POLLUTION; ARTICLE; AUTISM; BRAIN; CELL MATURATION; CHROMOSOME; CHROMOSOME 15Q; CHROMOSOME DUPLICATION; COPY NUMBER VARIATION; CPG ISLAND; DEVELOPMENTAL DISORDER; DIET; DNA DAMAGE; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; GAIN OF FUNCTION MUTATION; GENE DELETION; GENE DOSAGE; GENE REARRANGEMENT; GENETIC POLYMORPHISM; GENOMIC INSTABILITY; GENOMICS; GENOTYPE ENVIRONMENT INTERACTION; HIPPOCAMPUS; HUMAN; HUMAN GENOME; INTRACELLULAR SIGNALING; JAPAN; LOSS OF FUNCTION MUTATION; NERVE CELL; NEUROLOGIC DISEASE; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PRENATAL EXPOSURE; PROMOTER REGION; PSEUDOGENE; SIMPLE SEQUENCE REPEAT; SOCIOPATHY; TAIWAN; TANDEM REPEAT; TRANSPOSON; UTERUS; VITAMIN SUPPLEMENTATION;

EID: 79960118297     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.7.16353     Document Type: Article

References (102)

1. Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr 2009; 21.243-251PMID. 19663042.
2. Baccarelli A, Wright RO, Bollati V, Tarantini L, Litonjua AA, Suh HH, et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med 2009; 179.572-578. PMID. 19136372.
3. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 2007; 67.876-880. PMID. 17283117.
4. Tarantini L, Bonzini M, Apostoli P, Pegoraro V, Bollati V, Marinelli B, et al. Effects of particulate matter on genomic DNA methylation content and iNOS promoter methylation. Environ Health Perspect 2009; 117.217-22. PMID. 19270791.
5. Wright RO, Schwartz J, Wright RJ, Bollati V, Tarantini L, Park SK, et al. Biomarkers of lead exposure and DNA methylation within retrotransposons. Environ Health Perspect 118.790-795.PMID. 20064768.
6. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 1997; 94.10907-1012. PMID. 9380733.
7. Onishchenko N, Karpova N, Sabri F, Castren E, Ceccatelli S. Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. J Neurochem 2008; 106.1378-1387.PMID. 18485098.
8. Sato K, Fukata H, Kogo Y, Ohgane J, Shiota K, Mori C. Neonatal exposure to diethylstilbestrol alters expression of DNA methyltransferases and methylation of genomic DNA in the mouse uterus. Endocr J 2009; 56.131-139.PMID. 18997445.
9. Rusiecki JA, Baccarelli A, Bollati V, Tarantini L, Moore LE, Bonefeld-Jorgensen EC. Global DNA hypomethylation is associated with high serumpersistent organic pollutants in Greenlandic Inuit. Environ Health Perspect 2008; 116.1547-52.PMID. 19057709.
10. Desaulniers D, Xiao GH, Lian H, Feng YL, Zhu J, Nakai J, et al. Effects of mixtures of polychlorinated biphenyls, methylmercury and organochlorine pesticides on hepatic DNA methylation in prepubertal female Sprague-Dawley rats. Int J Toxicol 2009; 28.294-307.PMID. 19636072.
11. Kuratsune M, Yoshimura T, Matsuzaka J, Yamaguchi A. Yusho, a poisoning caused by rice oil contaminated with polychlorinated biphenyls. HSMHA Health Rep 1971; 86.1083-1091.PMID. 5157795.
12. Rogan WJ, Gladen BC, Hung KL, Koong SL, Shih LY, Taylor JS, et al. Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 1988; 241.334-336.PMID. 3133768.
13. Eriksson P, Jakobsson E, Fredriksson A. Brominated flame retardants. a novel class of developmental neurotoxicants in our environment? Environ Health Perspect 2001; 109.903-908.PMID. 11673118.
14. Guvenius DM, Aronsson A, Ekman-Ordeberg G, Bergman A, Noren K. Human prenatal and postnatal exposure to polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorobiphenylols and pentachlorophenol. Environ Health Perspect 2003; 111.1235-1241.PMID. 12842779.
15. Zepeda-Mendoza CJ, Lemus T, Yanez O, Garcia D, Valle-Garcia D, Meza-Sosa KF, et al. Identical repeated backbone of the human genome. BMC Genomics 11.60.PMID. 20096123.
16. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, et al. Origins and functional impact of copy number variation in the human genome. Nature 464.704-712.PMID. 19812545.
17. Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006; 7.85-97.PMID. 16418744.
18. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, et al. Detection of large-scale variation in the human genome. Nat Genet 2004; 36.949-51.PMID. 15286789.
19. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, et al. Large-scale copy number polymorphism in the human genome. Science 2004; 305.525-528.PMID. 15273396.
20. Caceres M, Lachuer J, Zapala MA, Redmond JC, Kudo L, Geschwind DH, et al. Elevated gene expression levels distinguish human from non-human primate brains. Proc Natl Acad Sci USA 2003; 100.13030-13035.PMID. 14557539.
21. Enard W, Khaitovich P, Klose J, Zollner S, Heissig F, Giavalisco P, et al. Intra- and interspecific variation in primate gene expression patterns. Science 2002; 296.340-343.PMID. 11951044.
22. Jiang Z, Tang H, Ventura M, Cardone MF, Marques-Bonet T, She X, et al. Ancestral reconstruction of segmental duplications reveals punctuated cores of human genome evolution. Nat Genet 2007; 39.1361-1368.PMID. 17922013.
23. De S, Teichmann SA, Babu MM. The impact of genomic neighborhood on the evolution of human and chimpanzee transcriptome. Genome Res 2009; 19.785-94.PMID. 19233772.
24. Alkan C, Kidd JM, Marques-Bonet T, Aksay G, Antonacci F, Hormozdiari F, et al. Personalized copy number and segmental duplication maps using nextgeneration sequencing. Nat Genet 2009; 41.1061-1067.PMID. 19718026.
25. Payseur BA, Jing P, Haasl RJ. A genomic portrait of human microsatellite variation. Mol Biol Evol 28.303-312.PMID. 20675409.
26. Stults DM, Killen MW, Pierce HH, Pierce AJ. Genomic architecture and inheritance of human ribosomal RNA gene clusters. Genome Res 2008; 18.13-18.PMID. 18025267.
27. Paredes S, Maggert KA. Ribosomal DNA contributes to global chromatin regulation. Proc Natl Acad Sci USA 2009; 106.17829-17834.PMID. 19822756.
28. Lin KW, Yan J. Endings in the middle. current knowledge of interstitial telomeric sequences. Mutat Res 2008; 658.95-110.PMID. 17921045.
29. Muotri AR, Chu VT, Marchetto MC, Deng W, Moran JV, Gage FH. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 2005; 435.903-910.PMID. 15959507.
30. Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, Mu Y, Lovci MT, et al. L1 retrotransposition in human neural progenitor cells. Nature 2009; 460.1127-1131.PMID. 19657334.
31. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455.237-241.PMID. 18668038.
32. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, et al. Strong association of de novo copy number mutations with autism. Science 2007; 316.445-449.PMID. 17363630.
33. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008; 455.232-236.PMID. 18668039.
34. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466.368-372.PMID. 20531469.
35. Cook EH Jr, Scherer SW. Copy-number variations associated with neuropsychiatric conditions. Nature 2008; 455.919-923.PMID. 18923514.
36. Ramocki MB, Zoghbi HY. Failure of neuronalhomeostasis results in common neuropsychiatric phenotypes. Nature 2008; 455.912-918.PMID. 18923513.
37. Hogart A, Leung KN, Wang NJ, Wu DJ, Driscoll J, Vallero RO, et al. Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J Med Genet 2009; 46.86-93.PMID. 18835857.
38. Hogart A, Wu D, Lasalle JM, Schanen NC. The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol Dis 2010; 38.181-191.PMID. 18840528.
39. Cook EH Jr, Lindgren V, Leventhal BL, Courchesne R, Lincoln A, Shulman C, et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 1997; 60.928-934.PMID. 9106540.
40. Mohandas TK, Park JP, Spellman RA, Filiano JJ, Mamourian AC, Hawk AB, et al. Paternally derived de novo interstitial duplication of proximal 15q in a patient with developmental delay. Am J Med Genet 1999; 82.294-300.PMID. 10051161.
41. Mao R, Jalal SM, Snow K, Michels VV, Szabo SM, Babovic-Vuksanovic D. Characteristics of two cases with dup(15)(q11.2-q12). one of maternal and one of paternal origin. Genet Med 2000; 2.131-135.PMID. 11397326.
42. Veltman MW, Craig EE, Bolton PF. Autism spectrum disorders in Prader-Willi and Angelman syndromes. a systematic review. Psychiatr Genet 2005; 15.243-254.PMID. 16314754.
43. Veltman MW, Thompson RJ, Craig EE, Dennis NR, Roberts SE, Moore V, et al. A paternally inherited duplication in the Prader-Willi/Angelman syndrome critical region. a case and family study. J Autism Dev Disord 2005; 35.117-127.PMID. 15796127.
44. Depienne C, Moreno-De-Luca D, Heron D, Bouteiller D, Gennetier A, Delorme R, et al. Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders. Biol Psychiatry 2009; 66.349-359.PMID. 19278672.
45. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196.261-282.PMID. 3656447.
46. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41.178-186.PMID. 19151715.
47. Rauch TA, Wu X, Zhong X, Riggs AD, Pfeifer GP. A human B cell methylome at 100-base pair resolution. Proc Natl Acad Sci USA 2009; 106.671-678.PMID. 19139413.
48. Rollins RA, Haghighi F, Edwards JR, Das R, Zhang MQ, Ju J, et al. Large-scale structure of genomic methylation patterns. Genome Res 2006; 16.157-163.PMID. 16365381.
49. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462.315-322.PMID. 19829295.
50. Xie H, Wang M, Bonaldo Mde F, Smith C, Rajaram V, Goldman S, et al. High-throughput sequencebased epigenomic analysis of Alu repeats in human cerebellum. Nucleic Acids Res 2009; 37.4331-4340.PMID. 19458156.
51. Carbone L, Harris RA, Vessere GM, Mootnick AR, Humphray S, Rogers J, et al. Evolutionary breakpoints in the gibbon suggest association between cytosine methylation and karyotype evolution. PLoS Genet 2009; 5.1000538.PMID. 19557196.
52. Ehrlich M. Cancer-linked DNA hypomethylation and its relationship to hypermethylation. Curr Top Microbiol Immunol 2006; 310.251-74.PMID. 16909914.
53. Shvachko LP. DNA hypomethylation as Achilles' heel of tumorigenesis. a working hypothesis. Cell Biol Int 2009; 33.904-910.PMID. 19446028.
54. Kim M, Trinh BN, Long TI, Oghamian S, Laird PW. Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells. Nucleic Acids Res 2004; 32.5742-5749.PMID. 15509869.
55. Kucharski R, Maleszka J, Foret S, Maleszka R. Nutritional control of reproductive status in honeybees via DNA methylation. Science 2008; 319.1827-1830.PMID. 18339900.
56. Waterland RA, Jirtle RL. Transposable elements. targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23.5293-5300.PMID. 12861015.
57. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA 2007; 104.13056-13061.PMID. 17670942.
58. Duthie SJ. Folate and cancer. how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 2011; 34.101-109.PMID. 20544289.
59. Beard CM, Panser LA, Katusic SK. Is excess folic acid supplementation a risk factor for autism? Med Hypotheses 2011; 77.15-17.PMID. 21454018.
60. Leeming RJ, Lucock M. Autism. Is there a folate connection? J Inherit Metab Dis 2009; 32.400-402.PMID. 19277892.
61. Rogers EJ. Has enhanced folate status during pregnancy altered natural selection and possibly autism prevalence? A closer look at a possible link. Med Hypotheses 2008; 71.406-10; DOI. 10.1016/j. mehy.2008.04.013.
62. Czeizel AE, Puho E. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome. case-control study. Nutrition 2005; 21.698-704.PMID.15925294.
63. Patterson D. Folate metabolism and the risk of Down syndrome. Downs Syndr Res Pract 2008; 12.93-97.PMID. 19026278.
64. Kerkel K, Schupf N, Hatta K, Pang D, Salas M, Kratz A, et al. Altered DNA methylation in leukocytes with trisomy 21. PLoS Genet 6.1001212; PMID. 21124956.
65. Hawkins RD, Hon GC, Lee LK, Ngo Q, Lister R, Pelizzola M, et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6.479-491.PMID. 20452322.
66. Ladd-Acosta C, Pevsner J, Sabunciyan S, Yolken RH, Webster MJ, Dinkins T, et al. DNA methylation signatures within the human brain. Am J Hum Genet 2007; 81.1304-1315.PMID. 17999367.
67. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008; 454.766-770.PMID. 18600261.
68. Lyall K, Pauls DL, Santangelo S, Spiegelman D, Ascherio A. Maternal early life factors associated with hormone levels and the risk of having a child with an autism spectrum disorder in the nurses health study II. J Autism Dev Disord 2011; 41.618-627.PMID. 20700638.
69. Shelton JF, Tancredi DJ, Hertz-Picciotto I. Independent and dependent contributions of advanced maternal and paternal ages to autism risk. Autism Res 2010; 3.30-39.PMID. 20143326.
70. Lee DH, Jacobs DR Jr, Porta M. Hypothesis. a unifying mechanism for nutrition and chemicals as lifelong modulators of DNA hypomethylation. Environ Health Perspect 2009; 117.1799-1802.PMID. 20049195.
71. Lasalle JM, Yasui DH. Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics 2009; 1.119-130.PMID. 20473347.
72. Schanen NC. Epigenetics of autism spectrum disorders. Hum Mol Genet 2006; 15.138-150.PMID. 16987877.
73. Feng J, Chang H, Li E, Fan G. Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system. J Neurosci Res 2005; 79.734-746.PMID. 15672446.
74. Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, et al. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 2010; 13.423-430.PMID. 20228804.
75. Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron 2007; 53.857-869.PMID. 17359920.
76. LaPlant Q, Vialou V, Covington HE, 3rd, Dumitriu D, Feng J, Warren BL, et al. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat Neurosci 2010; 13.1137-1143.PMID. 20729844.
77. Wu H, Coskun V, Tao J, Xie W, Ge W, Yoshikawa K, et al. Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 2010; 329.444-448.PMID. 20651149.
78. Bird AP, Wolffe AP. Methylation-induced repression- belts, braces and chromatin. Cell 1999; 99.451-454.
79. Ng HH, Bird A. DNA methylation and chromatin modification. Curr Opin Genet Dev 1999; 9.158-163.
80. Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Science 2007; 315.1141-1143.PMID. 17322062.
81. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription.Science 2008; 320.1224-1229.PMID.18511691.
82. Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for longrange interaction with active genes. Proc Natl Acad Sci USA 2007; 104.19416-194121.PMID. 18042715.
83. Georgel PT, Horowitz-Scherer RA, Adkins N, Woodcock CL, Wade PA, Hansen JC. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem 2003; 278.32181-32188.PMID. 12788925.
84. Horike S, Cai S, Miyano M, Cheng JF, Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 2005; 37.31-40.PMID. 15608638.
85. Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF, et al. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA 2005; 102.17551-17558.PMID. 16251272.
86. Squillaro T, Alessio N, Cipollaro M, Renieri A, Giordano A, Galderisi U. Partial silencing of methyl cytosine protein binding 2 (MECP2) in mesenchymal stem cells induces senescence with an increase in damaged DNA. Faseb J 24.1593-1603.PMID. 20065105.
87. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2. Nat Genet 1999; 23.185-188.
88. Van Esch H, Bauters M, Ignatius J, Jansen M, Raynaud M, Hollanders K, et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 2005; 77.442-453.PMID. 16080119.
89. Melissa BR, Sarika UP, Tavyev YJ, Feng Z, Claudia MBC, Christian PS, et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MECP2 duplication syndrome. Annals of Neurology 2009; 66.771-782.
90. Nagarajan RP, Hogart AR, Gwye Y, Martin MR, Lasalle JM. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 2006; 1.172-182.PMID. 17486179.
91. Muotri AR, Marchetto MC, Coufal NG, Oefner R, Yeo G, Nakashima K, et al. L1 retrotransposition in neurons is modulated by MeCP2. Nature 468.443-446.PMID. 21085180.
92. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004; 80.1611-1617.PMID. 15585776.
93. Nagarajan RP, Patzel KA, Martin M, Yasui DH, Swanberg SE, Hertz-Picciotto I, et al. MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res 2008; 1.169-178.PMID. 19132145.
94. Volkmar FR, Pauls D. Autism. Lancet 2003; 362.1133-1141.PMID. 14550703.
95. Lawler CP, Croen LA, Grether JK, Van de Water J. Identifying environmental contributions to autism. provocative clues and false leads. Ment Retard Dev Disabil Res Rev 2004; 10.292-302.PMID. 15666339.
96. Veenstra-Vanderweele J, Christian SL, Cook EH Jr. Autism as a paradigmatic complex genetic disorder. Annu Rev Genomics Hum Genet 2004; 5.379-405.PMID. 15485354.
97. Geschwind DH. Autism. many genes, common pathways? Cell 2008; 135.391-395.PMID. 18984147.
98. Betancur C, Sakurai T, Buxbaum JD. The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends Neurosci 2009; 32.402-412.PMID. 19541375.
99. Currenti SA. Understanding and determining the etiology of Autism. Cell Mol Neurobiol 2010; 30.161-171.PMID. 19774457.
100. Gregory SG, Connelly JJ, Towers AJ, Johnson J, Biscocho D, Markunas CA, et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med 2009; 7.62.PMID. 19845972.
101. Nguyen A, Rauch TA, Pfeifer GP, Hu VW. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. Faseb J 24.3036-3051.PMID. 20375269.
102. Schmidt RJ, Hansen RL, Hartiala J, Allayee H, Schmidt LC, Tancredi DJ, et al. Prenatal vitamins, one-carbon metabolism gene variants, and risk for Autism. Epidemiology 2011; 22.476-485.PMID.21610500.